secwatch.observer — SEC 8-K summary
======================================

Issuer:     SBC Medical Group Holdings Inc (SBC)
CIK:        0001930313
Form:       8-K
Filed at:   2025-03-28T23:59:59+00:00
Accession:  0001641172-25-001050
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SBC Medical Q4 revenue down 29% to $44M; FY 2024 net income up 18% to $47M
--------------------------------------------------------------------------

- Q4 2024 revenue $44M (down 29% YoY); net income $7M (down 54% YoY); EPS $0.06 (down 58%).
- Full-year 2024 revenue $205M (up 6% YoY); net income $47M (up 18% YoY); EPS $0.48 (up 14%).
- Q4 EBITDA $21M (down 22% YoY) with margin 47%; full-year EBITDA $89M (up 8% YoY) with margin 43%.
- Partner clinics grew by 43 to 251 as of Dec 31, 2024, expanding the clinic network.
- Income from operations fell 80% in Q4 to $5M but was nearly flat for the full year at $70M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1930313/000164117225001050/0001641172-25-001050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1930313/000164117225001050/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-001050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer